Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Combining minoxidil with phototherapy improves vitiligo treatment better than phototherapy alone.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Platelet-rich plasma (PRP) shows promise for treating melasma but needs more research for confirmation.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Upadacitinib improved multiple immune-related conditions in one patient.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Scoring systems help doctors assess and treat skin diseases effectively.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Higher IL-17A levels indicate more severe alopecia areata.

Lower BDNF levels link to worse depression in alopecia areata patients.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Pix Liquida may help treat alopecia areata.

Oral Apremilast effectively treats alopecia areata in most patients.

Vitamin D is important for skin health and can help treat and prevent various skin conditions.

Apremilast shows promise for several skin conditions but needs more research.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Skin infections and eczema were most common in all ages, acne in teens and young adults, and nutritional skin problems and infestations in children.

Baricitinib is more effective than methotrexate for severe alopecia areata.